OnabotulinumtoxinA Successfully Used as Migraine Prophylaxis During Pregnancy: A Case Report

Clicks: 206
ID: 261195
2014
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #14 of 76 articles by views in Military Medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
ABSTRACT. Botulinum toxin (btx) received U.S. Food and Drug Administration approval for migraine treatment in 2010 with a pregnancy category C. There are minim
Reference Key
y.2014militaryonabotulinumtoxina Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Robinson, Andrew Y.;Grogan, Patrick M.;
Journal Military Medicine
Year 2014
DOI
DOI not found
URL
http://dx.doi.org/10.7205/MILMED-D-13-00477
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine pregnancy adult female case reports Infant newborn pregnancy complications / prevention & control* botulinum toxins type a / therapeutic use* pmid:24902141 doi:10.7205/milmed-d-13-00477 andrew y robinson patrick m grogan acetylcholine release inhibitors / therapeutic use* apgar score migraine disorders / prevention & control*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.